Page last updated: 2024-08-26

sr141716 and Depressive Disorder, Major

sr141716 has been researched along with Depressive Disorder, Major in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Faludi, G; Halmy, L; Purebl, G; Rihmer, Z1
Després, JP; Pi-Sunyer, X; Scheen, A; Van Gaal, L1
Blüher, M1

Reviews

1 review(s) available for sr141716 and Depressive Disorder, Major

ArticleYear
[Association of obesity and depression].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2008, Volume: 10, Issue:4

    Topics: Anti-Obesity Agents; Antidepressive Agents; Appetite Depressants; Appetite Regulation; Bipolar Disorder; Circadian Rhythm; Cyclobutanes; Depression; Depressive Disorder, Major; Dietary Carbohydrates; Energy Intake; Ghrelin; Humans; Hypothalamo-Hypophyseal System; Insulin Resistance; Leptin; Obesity; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rimonabant; Seasonal Affective Disorder; Sleep Wake Disorders; Surveys and Questionnaires; Weight Gain; Weight Loss

2008

Other Studies

2 other study(ies) available for sr141716 and Depressive Disorder, Major

ArticleYear
Efficacy and safety of the weight-loss drug rimonabant.
    Lancet (London, England), 2008, Feb-16, Volume: 371, Issue:9612

    Topics: Anti-Obesity Agents; Depression; Depressive Disorder, Major; Humans; Obesity; Patient Selection; Piperidines; Pyrazoles; Rimonabant; Suicide

2008
Efficacy and safety of the weight-loss drug rimonabant.
    Lancet (London, England), 2008, Feb-16, Volume: 371, Issue:9612

    Topics: Anti-Obesity Agents; Depression; Depressive Disorder, Major; Humans; Obesity; Piperidines; Pyrazoles; Rimonabant

2008